Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-001378-29Phase 4Completed
Phase 4, randomised, double-blind trial of botulinum toxin type A in Anismus (DD) and Pelvic floor dyssynergia (PFD) (2 arms), sponsored by Bradford Teaching Hospitals NHS Foundation Trust. Primary endpoint: Improved defecation. Started Apr 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-001378-29.